Acute kidney injury (AKI) is one of the features of postresuscitation syndrome and can lead to acute renal failure. AKI occurrence is found to be frequent in patients undergoing ECMO and associated with development of multiorgan dysfunction and poor survival., In the critically ill patients treated with ECMO, the rate of renal replacement treatment (RRT) dependence ranges between 2% in bypass surgery patients and 65% in refractory postcardiotomy
cardiogenic shock patients., Moreover, the need for RRT is considered as an independent predictor of mortality in patients treated with ECMO.
Chen, "Extracorporeal membrane oxygenation support for adult postcardiotomy
cardiogenic shock," Annals of Thoracic Surgery, vol.
While Impella use is well described in postcardiotomy
, fulminant myocarditis, and cardiac arrest, we are not aware of prior reports describing Impella use for cardiogenic shock in patients with type 2 NSTEMI secondary to sepsis.
VA ECMO is most frequently adopted in cardiogenic shock caused by a variety of etiologies, such as postmyocardial infarction, fulminant myocarditis, peripartum cardiomyopathy, cardiac depression aggravated by septic shock, decompensated heart failure, and most commonly occurring postcardiotomy
shock, failure to wean off CPB, and extracorporeal CPR .
Results of pediatric mechanical assist for postcardiotomy
ventricular failure and cardiac arrest.
Calvi et al., "CentriMag venoarterial extracorporeal membrane oxygenation support as treatment for patients with refractory postcardiotomy
cardiogenic shock," ASAIO Journal, vol.
delirium usually develops on day 2 after surgery but can also be seen in the ICU, particularly if patients have a longer postoperative ICU stay than anticipated (Arend & Christensen, 2009).
Bayindir et al (8) achieved successful results in postcardiotomy
delirium with ondansetron, which is a 5H[T.sub.3] receptor antagonist.
Improved survival after Hemopump insertion in patients experiencing postcardiotomy
cardiogenic shock during cardiopulmonary bypass.
The researchers found that overall 1-year survival, regardless of subsequent heart transplantation or device removal, was 51.6% (n=669) in the primary device group and 30.8% (n=424) in the postcardiotomy
support in older patients should be performed in really selective cases," he said.
Autoimmune disease rarely develops and usually resolves spontaneously, as seen in postcommissurotomy syndrome (or postcardiotomy